Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1991
02/27/1991EP0414190A2 Phosphonate substituted amino or imino acids useful as antihypertensives
02/27/1991EP0414175A2 Use of xanthine derivatives to reduce nephrotoxicity
02/27/1991EP0414115A1 Granulates of riboflavine without excipients
02/27/1991EP0414078A2 Disubstituted (quinolin-2-yl-methoxy)-phenylacetic acid derivatives
02/27/1991EP0414076A1 Cyclic substituted (quinoline-2-yl-methoxy)phenylacetic acid derivatives
02/27/1991EP0414023A2 Pyrroloquinoline compounds
02/27/1991EP0414020A2 Process for the preparation of clausenamide and neoclausenamide and their derivatives
02/27/1991EP0414019A2 Subsituted N-(quinolin-2-yl-methoxy)benzylsulfonylureas
02/27/1991EP0414018A2 Process for the preparation of dehydrocycloclausenamide and its derivatives in the racemic form and as optically active (+)- or (-)-enantiomers
02/27/1991EP0413929A2 Use of an ace-inhibitor to treat or prevent depression
02/27/1991EP0413843A1 Dithiolane derivatives
02/27/1991EP0413828A1 Solid preparation of active vitamin d3 having improved stability
02/27/1991EP0413783A1 Thickening agents for aqueous systems
02/27/1991EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
02/27/1991EP0413757A1 Method for treating autoimmune disease using succinylacetone
02/27/1991EP0413751A1 Neurologically active compounds
02/27/1991EP0413709A1 Fatty amino acids, and homo- and hetero-oligomers and conjugates thereof
02/27/1991EP0413706A1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
02/27/1991EP0413700A1 New alkylphosphono- and phosphoserines, method for preparing them, and pharmaceutical substances containing them
02/27/1991EP0413694A1 Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker.
02/27/1991CN1049504A Acrylic acid salts, process for their preparation pharmaceutical compositions contining them and use in medicine
02/27/1991CN1049503A Process for preparation of macrocyclic compounds
02/27/1991CN1049502A Process of preparing antiviral compound
02/27/1991CN1049501A Azabicyclo quinolone carboxylic acids
02/27/1991CN1049500A Benzopyran compounds, processes for their production and pharmaceutical compositions
02/27/1991CN1049499A 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)- derivatives with properties of mucus-adjustment and antiischemia
02/27/1991CN1049497A Substituted benzoylurea compounds or their salts, processes for their production and antitumour compositions containing them
02/27/1991CN1049455A Pharmaceutical dosage form improving bioavailability
02/27/1991CN1049451A Antibiotic composition
02/27/1991CN1049450A Method and device for administering dexmedetomidine transdermally
02/27/1991CN1011788B Process for preparation of 6-(substituted) methylenepenicillanic acids and derivatives thereof
02/27/1991CN1011786B Process for preparing 4-hydroxycoumarin derivatives
02/27/1991CN1011784B Method for preparing medicines of antianaphylaxis and antibronchospasm of n-dibenzyl-diazacyclo-alkyl-alkyl-anilide
02/27/1991CN1011783B Process for preparation of cyclopentyl ethers
02/27/1991CN1011780B Process for producing phenoxyacetic acid derivatives
02/27/1991CN1011779B Synthetic method of diuretic bumetanide
02/27/1991CA2058287A1 Use of the (+) enantiomer of anipamil
02/26/1991WO1991002725A1 Derivatives of 5-amino-1,2,3,4 tetrahydro-acridine and applications as drugs
02/26/1991WO1991002542A1 Treatment of chronic inflammatory conditions
02/26/1991WO1991002522A1 Onset-hastened/enhanced antipyretic response
02/26/1991US4996358 Control, prevention rheumatic diseases
02/26/1991US4996347 Anticoagulant
02/26/1991US4996329 Derivatives of 1,4-dideoxy-1,4-imino-D-mannitol and a process for their preparation
02/26/1991US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke
02/26/1991US4996312 Porphyrin derivatives, and their production and use
02/26/1991US4996308 Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
02/26/1991US4996297 contraceptives for non-rodent mammals
02/26/1991US4996238 Method of treating diaper rash
02/26/1991US4996236 Therapeutic composition for hepatic encephalopathy
02/26/1991US4996235 3,4-diphenylbutanamines
02/26/1991US4996233 Method of reducing porphyrin toxicity using fatty acids
02/26/1991US4996230 Leukotriene antagonists
02/26/1991US4996228 Macrolide antibiotics
02/26/1991US4996227 Administering nontoxic antitumor agents
02/26/1991US4996226 Aminotetralin compounds
02/26/1991US4996225 Tri-phenyl alkane derivatives and their oestrogenic, anti-oestrogenic and progestanic uses
02/26/1991US4996224 1-benzyl-4- or 5-pyrrolidinomethyl-pyrrolidin-2-ones and nootropic method of use thereof
02/26/1991US4996222 Pharmaceutical formulations
02/26/1991US4996219 Imidazolidine derivatives as immunosuppressives
02/26/1991US4996218 Chloroaniline derivatives
02/26/1991US4996217 Pyridyl-substituted imidazoles, compositions containing same and methods of use thereof
02/26/1991US4996215 Piperidine derivative and pharmaceutical composition containing the same
02/26/1991US4996214 Respiratory systyem disorders
02/26/1991US4996213 Derivatives of 4-amino 3-carboxy naphthyridines and their pharmaceutical compositions
02/26/1991US4996211 Anticonvulsants, treating neurodegenerative diseases
02/26/1991US4996210 Cognition activators, nervous system disorders; muscarinic acetylcholine receptor agonists; 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane for example
02/26/1991US4996209 Ophthalmic antiinflammatory compositions comprising S(+)-flurbiprofen
02/26/1991US4996207 Three new non-polyglutamatable deazaaminopterins
02/26/1991US4996204 Antidiabetic agents
02/26/1991US4996203 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
02/26/1991US4996201 Alzheimer's disease
02/26/1991US4996200 Suppression of transaminases in serum
02/26/1991US4996198 Mixture of 2,4-diamino-5-(trisubstituted)benzyl-pyrimidine potentiated sulfonamide antibiotic with an ionophorous polyether
02/26/1991US4996195 Antiinflammatory agent; autoimmune disorders
02/26/1991US4996074 Tailored beta-prime stable triglyceride hardstock
02/26/1991US4996059 Composition for the treatment of keratin fibers, based on amphoteric polymer and cationic polymer
02/26/1991US4996058 Covered retard forms
02/26/1991US4996057 Human placental tissue proteins and a condensation product of n-methyl-p-methoxyphenethylamine with formaldehyde; hair growth
02/26/1991US4996043 Aqueous dispersion of triglyceride, polysacharide, silicone oil and an antifreeze
02/26/1991CA2064999A1 1,2,3,4-tetrahydroacridin-5-amine derivatives and their use as therapeutic agents
02/26/1991CA2023957A1 Cyclic ketone derivatives and pharmaceutical compositions containing same as well as a process for their preparation
02/26/1991CA2023952A1 Cyclic pyridine-2-,4 and -2,5-dicarboxylic acid diamides, processes for their preparation and their use
02/26/1991CA2023913A1 Compounds
02/26/1991CA2023905A1 Compounds
02/26/1991CA1280759C Benzoyl-ureas having acaricide and insecticide activity
02/26/1991CA1280755C2 6,7-dihydro-5,8- dimethyl-9-fluoro-1-oxo-1h,5h- benzo[ij]quinolizine-2-carboxylic acid and derivatives
02/26/1991CA1280754C Process for the preparation of heterocyclic substituted oxazolones
02/26/1991CA1280753C Process for preparing heterocyclic substituted- phenoxyalkyl isoxazoles and-furans
02/26/1991CA1280751C 6.alpha.-AMINO-3-AZABICYCLO ¬3.3.1| NONANE DERIVATIVES
02/26/1991CA1280749C Phenothiazine compounds
02/26/1991CA1280748C 1-(hydroxystyryl)-5h-2,3-benzodiazepine derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
02/26/1991CA1280747C Diaminopyrimido¬4,5-d|pyrimidine glycoside and glycotide and process
02/26/1991CA1280695C Nalbuphine-local anesthetic analgesic composition and method of producing analgesia
02/26/1991CA1280694C Method for using ketamine for prevention or reduction of the effects of stroke in a subject having increased risk for stroke
02/25/1991WO1991002716A2 Hydroxamic acid based collagenase inhibitors
02/25/1991CA2064786A1 Hydroxamic acid based collagenase inhibitors
02/25/1991CA2023829A1 (quinolin-2-yl-methoxy)phenylacetic acid derivatives containing cyclic substituents
02/25/1991CA2023776A1 Leukotriene synthesis-inhibiting disubstituted (quinolin-2-yl-methoxy) phenylacetic acid derivatives
02/25/1991CA2023609A1 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-–-reductase
02/24/1991WO1991002517A1 Process for preparation of an oil in water emulsion of a drug